Transfer of Bittium Corporation’s own shares

Bittium Corporation
Changes in company’s own shares

Transfer of Bittium Corporation’s own shares

Bittium Corporation stock exchange release, 9 November 2026 at 6.35 p.m. (CET+1)

Based on the decision of the Annual General Meeting, held on 22 April 2026, Bittium Corporation has on 6 November 2026 transferred a total of 2,779 own shares possessed by the company to the members of the Board of Directors of Bittium Corporation as part of the Board members’ annual remuneration. The share issue was based on the authorisation granted by the Annual General Meeting on 22 April 2026. After the transfer, the company possesses 152,394 own shares.

The Annual General Meeting held on 22 April 2026 resolved that the monthly remuneration be paid to the members of the Board of Directors as follows: EUR 4,400 to the Chairman of the Board of Directors and EUR 2,500 to the other members of the Board of Directors. In addition, the Annual General Meeting resolved that 50% of the total monthly remuneration of the members of the Board of Directors will be paid in a single instalment through a share issue of the company's treasury shares, directed to the members of the Board of Directors six business days after the publication of the company's business review for 1 January – 30 September 2026 and the valuation of which is based on the five trading-day volume-weighted average price of the Bittium Oyj share on Nasdaq Helsinki following the publication of the company's business review for 1 January – 30 September 2026.

The plan to pay the remuneration of members of the Board of Directors with the company’s own shares was announced on 22 April 2026 in a stock exchange release issued concerning the decisions of Bittium Corporation’s Annual General Meeting.
 

Further information:

Petri Toljamo
CEO
Tel. +358 40 344 2789 (Group Communications)

Distribution

Nasdaq Helsinki Ltd
Principal media

Bittium

Bittium specialises in the development of reliable and secure communications and connectivity solutions using the latest technologies and its deep expertise in radio technology accumulated over 40 years. Bittium provides its customers with innovative products and services, solutions based on its product platforms, R&D services, and high-quality information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measurement in the areas of cardiology and neurophysiology. Bittium’s net sales in 2025 were EUR 119.3 million and operating profit was EUR 19.4 million. Bittium Corporation is listed on Nasdaq Helsinki. www.bittium.com